Thus, the enrichment of JAK1 truncating frameshift mutations in dMMR/MSI EC at least partly explains their lack of IFNγ response, and may also partly explain the absence of a prognostic benefit of MMR loss in this tumour type. Here, JAK1 is linked to neoplasm.